Trials / Sponsors / Gracell Biotechnologies (Shanghai) Co., Ltd.
Gracell Biotechnologies (Shanghai) Co., Ltd.
Industry · 3 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of GC012F, CAR-T Therapy Targeting CD19 and BCMA in Chinese Participants With Relapsed or Refractory AL Relapsed/Refractory AL Amyloidosis | Phase 1 | 2025-10-29 |
| Recruiting | A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus Refractory Systemic Lupus Erythematosus | Phase 1 / Phase 2 | 2024-08-22 |
| Recruiting | A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2023-12-26 |